259 related articles for article (PubMed ID: 27310438)
21. Risk Analysis of Respiratory Syncytial Virus Among Infants in the United States by Birth Month.
Gantenberg JR; van Aalst R; Bhuma MR; Limone B; Diakun D; Smith DM; Nelson CB; Bengtson AM; Chaves SS; La Via WV; Rizzo C; Savitz DA; Zullo AR
J Pediatric Infect Dis Soc; 2024 Jun; 13(6):317-327. PubMed ID: 38738450
[TBL] [Abstract][Full Text] [Related]
22. Prophylaxis for respiratory syncytial virus with respiratory syncytial virus-immunoglobulin intravenous among preterm infants of thirty-two weeks gestation and less: reduction in incidence, severity of illness and cost.
Atkins JT; Karimi P; Morris BH; McDavid G; Shim S
Pediatr Infect Dis J; 2000 Feb; 19(2):138-43. PubMed ID: 10694001
[TBL] [Abstract][Full Text] [Related]
23. Impact of the Withdrawal of Palivizumab Immunoprophylaxis on the Incidence of Respiratory Syncytial Virus (RSV) Hospitalizations Among Infants Born at 33 to 35 Weeks' Gestational Age in the Province of Quebec, Canada: The RSV-Quebec Study.
Papenburg J; Defoy I; Massé E; Caouette G; Lebel MH
J Pediatric Infect Dis Soc; 2021 Apr; 10(3):237-244. PubMed ID: 32530035
[TBL] [Abstract][Full Text] [Related]
24. A Retrospective Cohort Study on Infant Respiratory Tract Infection Hospitalizations and Recurrent Wheeze and Asthma Risk: Impact of Respiratory Syncytial Virus.
van Wijhe M; Johannesen CK; Simonsen L; Jørgensen IM; ; Fischer TK
J Infect Dis; 2022 Aug; 226(Suppl 1):S55-S62. PubMed ID: 35426942
[TBL] [Abstract][Full Text] [Related]
25. Respiratory disorders and hospitalization rates during the second RSV season in preterm infants who received palivizumab prophylaxis during their first RSV season.
Fanos V; Scarcella A; Puddu M; Gallini F; Tuminelli F; Bragetti P; Gallina MR; Quartulli L; Benincori N; Citro G; Via LD; Barera G; DI Luzio Paparatti U; Merolla R; Romano GV; Guida G; Silvestri M; Rossi GA
J Chemother; 2009 Jun; 21(3):302-10. PubMed ID: 19567351
[TBL] [Abstract][Full Text] [Related]
26. Prevalence, risk factors and clinical characteristics of respiratory syncytial virus-associated lower respiratory tract infections in Kelantan, Malaysia.
Teck KS; Mac Guad R; Van Rostenberghe AH; Hua GS
J Med Virol; 2019 Sep; 91(9):1608-1615. PubMed ID: 31074499
[TBL] [Abstract][Full Text] [Related]
27. Cost-analysis of Withdrawing Immunoprophylaxis for Respiratory Syncytial Virus in Infants Born at 33-35 Weeks Gestational Age in Quebec: A Multicenter Retrospective Study.
Papenburg J; Saleem M; Teselink J; Li A; Caouette G; Massé É; Lanctôt KL
Pediatr Infect Dis J; 2020 Aug; 39(8):694-699. PubMed ID: 32379195
[TBL] [Abstract][Full Text] [Related]
28. An outbreak of RSV infections in a neonatology clinic during the RSV-season.
Vakrilova L; Nikolova SH; Slavov S; Radulova P; Slancheva B
BMC Pediatr; 2021 Dec; 21(1):567. PubMed ID: 34895173
[TBL] [Abstract][Full Text] [Related]
29. The Burden of Respiratory Syncytial Virus in Children Under 2 Years of Age in a Rural Community in Maharashtra, India.
Satav A; Crow R; Potdar V; Dani V; Satav S; Chadha M; Hessong D; Carosone-Link P; Palaskar S; Simões EAF
Clin Infect Dis; 2021 Sep; 73(Suppl_3):S238-S247. PubMed ID: 34472575
[TBL] [Abstract][Full Text] [Related]
30. Effects of Chronologic Age and Young Child Exposure on Respiratory Syncytial Virus Disease among US Preterm Infants Born at 32 to 35 Weeks Gestation.
Simões EA; Anderson EJ; Wu X; Ambrose CS
PLoS One; 2016; 11(11):e0166226. PubMed ID: 27898687
[TBL] [Abstract][Full Text] [Related]
31. Clinical relevance of prevention of respiratory syncytial virus lower respiratory tract infection in preterm infants born between 33 and 35 weeks gestational age.
Carbonell-Estrany X; Bont L; Doering G; Gouyon JB; Lanari M
Eur J Clin Microbiol Infect Dis; 2008 Oct; 27(10):891-9. PubMed ID: 18629558
[TBL] [Abstract][Full Text] [Related]
32. Prospective validation of a prognostic model for respiratory syncytial virus bronchiolitis in late preterm infants: a multicenter birth cohort study.
Blanken MO; Koffijberg H; Nibbelke EE; Rovers MM; Bont L;
PLoS One; 2013; 8(3):e59161. PubMed ID: 23554987
[TBL] [Abstract][Full Text] [Related]
33. Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.
McLaurin KK; Farr AM; Wade SW; Diakun DR; Stewart DL
J Perinatol; 2016 Nov; 36(11):990-996. PubMed ID: 27490190
[TBL] [Abstract][Full Text] [Related]
34. Respiratory syncytial virus associated illness in high-risk children and national characterisation of the circulating virus genotype in South Africa.
Madhi SA; Venter M; Alexandra R; Lewis H; Kara Y; Karshagen WF; Greef M; Lassen C
J Clin Virol; 2003 Jul; 27(2):180-9. PubMed ID: 12829040
[TBL] [Abstract][Full Text] [Related]
35. The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestation.
Law BJ; Langley JM; Allen U; Paes B; Lee DS; Mitchell I; Sampalis J; Walti H; Robinson J; O'Brien K; Majaesic C; Caouette G; Frenette L; Le Saux N; Simmons B; Moisiuk S; Sankaran K; Ojah C; Singh AJ; Lebel MH; Bacheyie GS; Onyett H; Michaliszyn A; Manzi P; Parison D
Pediatr Infect Dis J; 2004 Sep; 23(9):806-14. PubMed ID: 15361717
[TBL] [Abstract][Full Text] [Related]
36. Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group.
Carbonell-Estrany X; Quero J; Bustos G; Cotero A; Doménech E; Figueras-Aloy J; Fraga JM; García LG; García-Alix A; Del Río MG; Krauel X; Sastre JB; Narbona E; Roqués V; Hernández SS; Zapatero M
Pediatr Infect Dis J; 2000 Jul; 19(7):592-7. PubMed ID: 10917214
[TBL] [Abstract][Full Text] [Related]
37. FLIP-2 Study: risk factors linked to respiratory syncytial virus infection requiring hospitalization in premature infants born in Spain at a gestational age of 32 to 35 weeks.
Figueras-Aloy J; Carbonell-Estrany X; Quero-Jiménez J; Fernández-Colomer B; Guzmán-Cabañas J; Echaniz-Urcelay I; Doménech-Martínez E;
Pediatr Infect Dis J; 2008 Sep; 27(9):788-93. PubMed ID: 18664927
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of respiratory syncytial virus infection in Italian infants hospitalized for acute lower respiratory tract infections, and association between respiratory syncytial virus infection risk factors and disease severity.
Lanari M; Giovannini M; Giuffré L; Marini A; Rondini G; Rossi GA; Merolla R; Zuccotti GV; Salvioli GP;
Pediatr Pulmonol; 2002 Jun; 33(6):458-65. PubMed ID: 12001280
[TBL] [Abstract][Full Text] [Related]
39. Hospitalisation of late preterm infants due to lower respiratory tract infections in Lithuania, Latvia, and Estonia: incidence, disease severity, and risk factors.
Drazdienė N; Tamelienė R; Kviluna D; Saik P; Saik E; Zaikauskienė J
Acta Med Litu; 2018; 25(2):76-85. PubMed ID: 30210241
[TBL] [Abstract][Full Text] [Related]
40. Respiratory syncytial virus infection in infants in rural Nepal.
Chu HY; Katz J; Tielsch J; Khatry SK; Shrestha L; LeClerq SC; Magaret A; Kuypers J; Steinhoff M; Englund JA
J Infect; 2016 Aug; 73(2):145-54. PubMed ID: 27241525
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
